← All companies

CRDF

Cardiff Oncology, Inc.

CRDF Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$0.93

+0.08 +9.88%

Key statistics

from XBRL data in SEC filings

Market cap

$63.9M

Revenue (TTM)

$525K

Net income (TTM)

$1.04M

EPS (TTM)

$-0.67

P/E ratio

—

Dividend yield

—

Free cash flow

-$38.0M

Cash

$8.54M

Total assets

$49.2M

Gross margin

—

52-week range

$0.76 – $3.31

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Other events Jul 16, 2026 8-K Shareholder vote results Jun 11, 2026 8-K Regulation FD disclosure Jun 3, 2026 8-K Entered a material agreement May 29, 2026 8-K Other events May 19, 2026 8-K Results of operations (earnings release) May 14, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Director or officer change; Other events Apr 9, 2026 8-K Entered a material agreement; Director or officer change Apr 2, 2026 8-K Regulation FD disclosure Feb 25, 2026 8-K Completed an acquisition or disposition Feb 24, 2026 10-K Fiscal year ended 2025-12-31 Feb 24, 2026 8-K Director or officer change; Other events Jan 27, 2026 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jul 29, 2025 10-Q Quarter ended 2025-06-30 Jul 29, 2025 8-K Shareholder vote results Jun 26, 2025 8-K Director or officer change; Other events Jun 17, 2025 8-K Results of operations (earnings release) May 8, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) Feb 27, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Amended charter or bylaws Jan 6, 2025 8-K Entered a material agreement; Other events Dec 10, 2024 8-K Regulation FD disclosure; Other events Dec 10, 2024 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Aug 8, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Shareholder vote results Jun 20, 2024 8-K Amended charter or bylaws; Other events Jun 3, 2024 8-K Results of operations (earnings release) May 2, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Regulation FD disclosure Apr 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Feb 29, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Regulation FD disclosure Jan 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 2, 2023 10-Q Quarter ended 2023-09-30 Nov 2, 2023